Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.2 (
PDK1
)
2,238
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CXCL16
, a recently discovered transmembrane chemokine, is expressed in human aortic smooth muscle cell (ASMC). It facilitates uptake of low density lipoproteins by macrophages, resulting in foam cell formation. However, it is not known whether ASMC express CXCR6, the receptor for
CXCL16
, or whether
CXCL16
affects ASMC biology. To dissect the biological and signal transduction pathways elicited by
CXCL16
, human aortic smooth muscle cells (HASMC) were treated with pharmacological inhibitors or transiently transfected with pathway-specific dominant-negative or kinase-dead expression vectors prior to the addition of
CXCL16
. HASMC expressed CXCR6 at basal conditions. Exposure of HASMC to
CXCL16
increased NF-kappa B DNA binding activity, induced kappa B-driven luciferase activity, and up-regulated tumor necrosis factor-alpha expression in an NF-kappa B-dependent manner. However, treatment with pertussis toxin (G(i) inhibitor), wortmannin or LY294002 (phosphatidylinositol 3-kinase (PI3K inhibitors)), or Akt inhibitor or overexpression of dominant-negative (dn) PI3K gamma, dnPDK-1, kinase-dead (kd) Akt, kdIKK-beta, dnIKK-gamma, dnI kappa B-alpha, or dnI kappa B-beta significantly attenuated
CXCL16
-induced NF-kappa B activation. Furthermore,
CXCL16
increased cell-cell adhesion and induced cellular proliferation in an NF-kappa B-dependent manner. In conclusion,
CXCL16
is a potent and direct activator of NF-kappaB and induces kappa B-dependent proinflammatory gene transcription.
CXCL16
-mediated NF-kappa B activation occurred via heterotrimeric G proteins, PI3K,
PDK
-1, Akt, and I kappa B kinase (IKK).
CXCL16
induced I kappa B phosphorylation and degradation. Most importantly,
CXCL16
increased cell-cell adhesion and induced kappa B-dependent ASMC proliferation, indicating that
CXCL16
may play an important role in the development and progression of atherosclerotic vascular disease.
...
PMID:CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. 1462 85
Decidualization renders the endometrium transiently receptive to an implanting blastocyst although the underlying mechanisms remain incompletely understood. The aim of this study was to determine the role of
chemokine CXCL16
and its receptor CXCR6 in the decidualization during pregnancy. Here, the expression of
CXCL16
was investigated in endometrial tissues, decidua and placenta in this study. Compared with endometrial tissue, protein expression of
CXCL16
was significantly higher in tissues from the fertile control samples, especially in villus. Meanwhile, the primary trophoblast cells and decidual stromal cells (DSCs) secreted more
CXCL16
and expressed higher CXCR6 compared to endometrial stromal cells (ESCs) in vitro. Stimulation with the inducer of decidualization (8-bromoadenosine 3',5'-cyclic with medroxyprogesterone acetate, 8-Br-cAMP plus MPA) significantly upregulated the expression of
CXCL16
and CXCR6 in ESCs in vitro. After treatment with exogenous recombinant human
CXCL16
(rhCXCL16) or trophoblast-secreted CXLC16, decidualised ESCs showed a significant decidual response, mainly characterised by increased prolactin (PRL) secretion. Simultaneously, PI3K/
PDK1
/AKT/Cyclin D1 pathway in decidualised ESCs were activated by rhCXCL16, and AKT inhibitor GS 690693 abolished the PRL secretion of ESCs that was triggered by rhCXCL16. Finally, the impaired
CXCL16
/CXCR6 expression could be observed at the maternal-foetal interface from patients who have experienced spontaneous abortion. This study suggests that the
CXCL16
/CXCR6 axis contributes to the progression of ESC decidualization by activating PI3K/
PDK1
/AKT/Cyclin D1 pathway. It unveils a new paradigm at the maternal-foetal interface in which
CXCL16
is an initiator for the molecular crosstalk that enhances decidualization of ESCs.
...
PMID:CXCL16/CXCR6 interaction promotes endometrial decidualization via the PI3K/AKT pathway. 3062 Jul 18